Disclosed positions
| MAPLIGHT THERAPEUTICS INC | MPLT | COM | $34,048,394 | 950,011 | SH | None |
| TYRA BIOSCIENCES INC | TYRA | COM | $32,875,778 | 1,029,298 | SH | None |
| ENTRADA THERAPEUTICS INC | TRDA | COM | $29,854,949 | 4,056,379 | SH | None |
| PHARVARIS N V | PHVS | COM | $27,581,008 | 797,600 | SH | None |
| CAMP4 THERAPEUTICS CORP | CAMP | COM | $25,647,928 | 5,869,091 | SH | None |
| ARTIVA BIOTHERAPEUTICS INC | ARTV | COM | $22,827,049 | 2,353,304 | SH | None |
| TECTONIC THERAPEUTIC INC | TECX | COM | $20,853,938 | 606,660 | SH | None |
| ZENTALIS PHARMACEUTICALS INC | ZNTL | COM | $19,147,378 | 3,947,913 | SH | None |
| CELLDEX THERAPEUTICS INC NEW | CLDX | COM NEW | $18,503,417 | 497,270 | SH | None |
| EYEPOINT INC | EYPT | COM NEW | $15,015,000 | 1,050,000 | SH | None |
| BIOHAVEN LTD | BHVN | COM | $10,995,903 | 738,972 | SH | None |
| SURROZEN INC | SRZN | COM NEW | $7,038,938 | 271,250 | SH | None |
| SKYE BIOSCIENCE INC | Unresolved | COM NEW | $6,712,366 | 9,681,763 | SH | None |
| ALX ONCOLOGY HLDGS INC | ALXO | COM | $6,328,663 | 3,057,325 | SH | None |
| PROTARA THERAPEUTICS INC | TARA | COM STK | $5,232,567 | 1,369,782 | SH | None |
| SILENCE THERAPEUTICS PLC | SLN | ADS | $5,228,676 | 476,200 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 1 positions lack a resolved ticker and 0 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.